著者 松岡 賢市| 青山 一利| 小山 幹子| 橋本 大吾| 朝倉 昇司| 一戸 辰夫| 谷本 光音| 豊嶋 崇徳|
発行日 2008-05-01
出版物タイトル 岡山医学会雑誌
120巻
1号
資料タイプ 学術雑誌論文
著者 谷本 光音|
発行日 2008-05-01
出版物タイトル 岡山医学会雑誌
120巻
1号
資料タイプ 学術雑誌論文
著者 木浦 勝行| 瀧川 奈義夫| 尾瀬 功| 八杉 昌幸| 越智 宣昭| 原田 大二郎| 谷本 光音|
発行日 2008-01-04
出版物タイトル 岡山医学会雑誌
119巻
3号
資料タイプ 学術雑誌論文
著者 谷本 安| 佐久川 亮| 木浦 勝行| 谷本 光音|
発行日 2005-01-31
出版物タイトル 岡山医学会雑誌
116巻
3号
資料タイプ 学術雑誌論文
著者 木浦 勝行| 谷本 安| 田端 雅弘| 金廣 有彦| 上岡 博| 谷本 光音| 渡邊 都貴子| 草野 展周| 小出 典男|
発行日 2005-05-30
出版物タイトル 岡山医学会雑誌
115巻
1号
資料タイプ 学術雑誌論文
著者 谷本 光音|
発行日 2001-12-31
出版物タイトル 岡山医学会雑誌
113巻
3号
資料タイプ 学術雑誌論文
JaLCDOI 10.18926/14750
タイトル(別表記) 気管支喘息の low attenuation are (LAA) に対する長期喫煙の影響-4年間の経過観察-
フルテキストURL 73_010_018.pdf
著者 光延 文裕| 芦田 耕三| 保﨑 泰弘| 柘野 浩史| 岡本 誠| 西田 典数| 永田 拓也| 高田 真吾| 横井 正| 中井 睦郎| 谷崎 勝朗| 谷本 光音|
抄録 Background-The influence of cigarette smoking on the pathogenesis of asthma in the elderly remains controversial. This study attempts to estimate longitudinal changes in HRCT (high resolution computed tomography) parameters and pulmonary function parameters obtained for ex-smokers and never-smokers in asthmatics during 4-yr follow-up period. Methods-Fourteen asthmatics (6 ex-smokers and 8 never-smokers) were studied to determine the influence of aging and cigarette smoking on pulmonary function, and mean lung density (MLD) and the relative area of the lung showing attenuation values less than -950 HU (RA950) on HRCT scans. Results-The values of FVC and FEV1, were significantly more decreased in asthmatics without a smoking history during 4-yr follow-up period. The values of FVC, FEV1, FEV1/FVC and DLco/VA were significantly decreased and RV/TLC were significantly increased in asthmatics with a smoking history over 4 years, and annual decline in FEV1 ex-smokers was larger than that in never-smokers. In the upper lung field, inspiratory MLD was observed to shift in a negative direction and inspiratory RA950 was found to increase during 4-yr observation period in ex-smokers, but not in never-smokers. In the middle lung field, inspiratory RA950 was significantly enhanced in both two groups. Although expiratory MLD, expiratory RA950 and exp RA950/ins RA950 were observed to change significantly during the observation period in ex-smokers, no changes were observed in never-smokers. Conclusion-These results suggest that aging augments airspace enlargement predominantly in the middle lung field, while long term cigarette smoking further worsens emphysematous alterations in the upper lung field.
キーワード lung density high resolution computed tomography asthma
出版物タイトル 岡大三朝医療センター研究報告
発行日 2003-02-01
73巻
開始ページ 10
終了ページ 18
ISSN 1348-1258
言語 English
論文のバージョン publisher
NAID 120002308656
JaLCDOI 10.18926/14768
タイトル(別表記) 気管支喘息に対する温泉療法とα-リノレン酸強化食の効果
フルテキストURL 73_055_063.pdf
著者 岡本 誠| 芦田 耕三| 光延 文裕| 保崎 泰弘| 柘野 浩史| 西田 典数| 永田 拓也| 横井 正| 高田 真吾| 谷崎 勝朗| 谷本 光音|
抄録 N-3 fatty acids are reportedly effective for asthma. In addition, spa therapy has been reported to be effective for patients with asthma. In the present study, the effects of spa therapy combined with perilla seed oil- rich diet (rich in n-3 fatty acid)were examined on asthma. A total of 14 asthmatic patients had a complex spa therapy and consumed a perilla seed oil- rich diet - rich in a -linolenic acid (alpha-LNA) for 8 weeks. Generation of leukotriene (LT) C4 by leucocytes, respiratory function were analyzed. The generation of LTC4 by leucocytes decreased significantly for 2, 4 and 8 weeks (P<O.05). Peak expiratory flow (PEF) values increased significantly for 2,4, 6 and 8 weeks (P<O.05). The values of ventilatory parameters [forced vital capacity (FVC) , forced expiratory volume in one second (FEV(1)) forced expiratory flow after 25% of expired FVC (FEF(25)), forced expiratory flow after 75% of expired FVC (FEF (75)) • mean expiratory flow during the middle half of the FVC (FEF(25-75)) ] revealed a significant increase after 4 and 8 weeks of the modified diet (P<O.05). The results suggest that spa therapy combined with a perilla seed oil- rich diet are effective in the treatment of asthma in terms of its ability to suppress LTC4 generation by leucocytes, and in inducing an improvement of pulmonary function.
キーワード bronchial asthma spa therapy perilla seed oil alpha -linolenic acid Leukotriene C4
出版物タイトル 岡大三朝医療センター研究報告
発行日 2003-02-01
73巻
開始ページ 55
終了ページ 63
ISSN 1348-1258
言語 English
論文のバージョン publisher
NAID 120002308428
JaLCDOI 10.18926/14774
タイトル(別表記) A case of Parkinson's disease associated with bromocriptine - induced leukopenia and throm-bocytopenia
フルテキストURL 73_084_087.pdf
著者 高田 真吾| 御舩 尚史| 光延 文裕| 岡本 誠| 西田 典数| 柘野 浩史| 芦田 耕三| 保崎 泰弘| 横井 正| 谷崎 勝朗| 新谷 憲治| 谷本 光音|
抄録 症例は67歳,女性。以前からパーキンソン病にて加療されていたが,リハビリテーション目的で当院入院した.入院時白血球数,血小板数正常であったが,bromocriptine投与開始後白血球減少,血小板減少を認めた.薬剤性白血球減少症及び血小板減少症を疑い, bromocriptine投与中止するとともにfilgrastim投与により,白血球減少,血小板減少は改善した。誘発試験施行し白血球減少を認めた。Bromocriptineによる白血球減少症,血小板減少症の報告は少なく,我々の検索しえた範円内では本症例を含めて2例のみであった。Bromocriptineには安全性や神経保護作用に関して多くのデータの蓄積があるが,安全性に十分な注意が必要であると考えられた。
キーワード パーキンソン病 (Parkinson's disease) ブロモクリプチン (Bromocriptine) 白球血減少症 (Leukopenia) 血小板減少症 (Thrombocytopenia) フィルグラスチム (Filgrastim)
出版物タイトル 岡大三朝医療センター研究報告
発行日 2003-02-01
73巻
開始ページ 84
終了ページ 87
ISSN 1348-1258
言語 Japanese
論文のバージョン publisher
NAID 120002308217
JaLCDOI 10.18926/14775
タイトル(別表記) A case of anti - neutrophil cytoplasmic autoantibody-associated vasculitis: Resolution after early diagnosis
フルテキストURL 73_088_092.pdf
著者 市川 裕久| 芦田 耕三| 小野 勝一郎| 高田 真吾| 横井 正| 永田 拓也| 岡本 誠| 柘野 浩史| 西田 典数| 保﨑 泰弘| 光延 文裕| 谷崎 勝朗| 野口 菩範| 谷本 光音|
抄録 症例は76歳男性03年前肺気腫と診断された。今回呼吸器リハビリテーション目的で当院に入院の運びとなった。入院時より37-38'Cの発熱を認め,下気道感染を疑い抗生剤で加療したが改善しなかった.入院時の検尿検査で蛋白・潜血陽性であり,血清MPO-ANCAが307U/mlと高値を示した。血清クレアチニン値も徐々に上昇してきたため,MPO-ANCA関連血管炎と診断した.プレドニゾロン投与を開始したところ,症状及び検査所見は速やかに改善した.
キーワード ANCA関連血管炎 早期診断 顕微鏡的多発血管炎
出版物タイトル 岡大三朝医療センター研究報告
発行日 2003-02-01
73巻
開始ページ 88
終了ページ 92
ISSN 1348-1258
言語 Japanese
論文のバージョン publisher
NAID 120002308580
JaLCDOI 10.18926/14839
タイトル(別表記) 脂質代謝に関連した気管支喘息患者における白血球ロイコトリエン産生能に対するα-リノレン酸食の効果
フルテキストURL 72_045_054.pdf
著者 岡本 誠| 光延 文裕| 芦田 耕三| 保崎 泰弘| 柘野 浩史| 西田 典教| 横井 正| 高田 真吾| 谷崎 勝朗| 谷本 光音|
抄録 Dietary sources of a -linolenic acid, such as perilla seed oil, may have the capacity to inhibit the generation of leukotrienes (LTs) by leucocytes in patients with asthma, as has been reported with the consumption of other long - chain n- 3 fatty a-cids. The factors affecting the suppression of leukotriene (LT) C4 generation by leucocytes were examined by comparing the clinical features of patients with asthma who had been given dietary perilla seed oil (n - 3 fatty acids). Group A consisted of patients in whom the leucocyte generation of dietary perilla seed oil LTC4 was suppressed by this procedure. Group B consisted of those in whom LTC4 generation was not suppressed. LTC4 generation by leucocytes significantly decreased in group A for two (P<0.05) and four weeks (P<O. OS), conversely, significantly increased in group B for four weeks (p<O. OS). The two study groups differed significantly in LTC4 generation by leucocytes after four weeks of dietary supplementation (P<0.05). Ventilatory parameters such as peak expiratory flow (PEF) , forced vital capacity (FVC) and forced expiratory volume in one second (FEV(1.O)) increased significantly after four weeks of dietary supplementation in group A (P<0.05). Values of PEF, FVC, FEV(1.O) and V(25) between groups A and B significantly differed prior to dietary supplementation. Serum levels of total cholesterol, LDL- cholesterol and phospholipid were significantly decreased by dietary supplementation in group A after four weeks. Serum levels of total-choles terol, triglyceride, HDL-Cholesterol, LDL-Cholesterol and phospholipid values between the two study groups differed significantly prior to dietary supplementation. Serum levels of triglyceride and LDL- cholesterol differed significantly between the two study groups after four weeks of dietary supplementation. The effects of dietary supplementation with perilla seed oil to patients with asthma by suppressing the generation of LTC4 is associated with clinical features such as respiratory function and lipometabolism.
キーワード alpha -linolenic acid leukotrieneC4 bronchial asthma lipometabolism
出版物タイトル 岡大三朝分院研究報告
発行日 2002-02-01
72巻
開始ページ 45
終了ページ 54
ISSN 0918-7839
言語 English
論文のバージョン publisher
NAID 120002308212
JaLCDOI 10.18926/14842
タイトル(別表記) The relationship between the magnetic resonance imaging of the lumbar spine and lowback pain
フルテキストURL 72_066_070.pdf
著者 高田 真吾| 横井 正| 西田 典数| 岡本 誠| 柘野 浩史| 芦田 耕三| 保﨑 泰弘| 御舩 尚志| 光延 文裕| 谷崎 勝朗| 新谷 憲治| 谷本 光音|
抄録 (目的) MRlは腰痛をきたす疾患の診断に必須な検査法である。腰痛と腰椎MRl所見との関係を明らかにすることを目的として検討した。(対象と方法)腰痛を訴えた30例を対象とし、腰椎MRl所見の頻度を調査した。全例に温泉療法を施行した。  (結果)全症例において腰椎MRl上異常所見を認めた。少なくとも1つ以上の椎間板の変性病変をもつ症例は30例中27例(90% )で、椎間板変性はL4/5levelで最も多く認められた(30例中18例)。椎間板ヘルニア を示す症例は30例中10例(33.3% )であった。神経根圧迫を持つ症例は30例中8例(26.7% )であった。腰椎圧迫骨折を持つ症例は30例中6例(20% )であった。温泉療法により腰痛が改善した症例は30例中17例(56.7% )であった。  (結論)腰痛症患者は腰椎MR止異常所見を有した。温泉療法により腰痛の改善を認めたので、MRL上で認めた形態学的異常は必ずしも機能的異常や症状に直結しないと思われた。
キーワード 腰痛症 (Disc disease) MRl (Magnetic resonance imaglng) 椎間板変性 (Lumbar spine)
出版物タイトル 岡大三朝分院研究報告
発行日 2002-02-01
72巻
開始ページ 66
終了ページ 70
ISSN 0918-7839
言語 Japanese
論文のバージョン publisher
NAID 120002308103
著者 松岡 順治| 猶本 良夫| 田端 雅弘| 白川 靖博| 堀田 勝幸| 谷本 光音| 田中 紀章|
発行日 2009-04-01
出版物タイトル 岡山医学会雑誌
121巻
1号
資料タイプ 学術雑誌論文
著者 市原 英基| 松岡 順治| 瀧川 奈義夫| 松崎 孝| 勝井 邦彰| 木浦 勝行| 谷本 光音|
発行日 2009-12-01
出版物タイトル 岡山医学会雑誌
121巻
3号
資料タイプ 学術雑誌論文
JaLCDOI 10.18926/AMO/30737
フルテキストURL fulltext.pdf
著者 Suzaki, Noriyuki| Hiraki, Akio| Takigawa, Nagio| Ueoka, Hiroshi| Tanimoto, Yasushi| Kozuki, Toshiyuki| Tabata, Masahiro| Kanehiro, Arihiko| Kiura, Katsuyuki| Tanimoto, Mitsune|
抄録 A 71-year-old Japanese man with adenocarcinoma of the lung developed interstitial pneumonia after treatment with paclitaxel. The patient had acute chills and fever on the fourth day after the second exposure to paclitaxel, rapidly got worse despite empiric therapies, and developed prolonged respiratory failure requiring mechanical ventilation. Four months later, he died of respiratory failure due to progression of both interstitial pneumonia and lung cancer. This is the first case developing fatal paclitaxel-induced pulmonary toxicity to date. Interstitial pneumonia should be considered one of the possible life-threatening complications during treatment with paclitaxel.
キーワード paclitaxel adverse effect lung cancer interstitial pneumonia
Amo Type Article
発行日 2006-10
出版物タイトル Acta Medica Okayama
60巻
5号
出版者 Okayama University Medical School
開始ページ 295
終了ページ 298
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
論文のバージョン publisher
査読 有り
PubMed ID 17072376
Web of Science KeyUT 000241509000006
JaLCDOI 10.18926/AMO/30751
フルテキストURL fulltext.pdf
著者 Kitajima, Takuji| Nishii, Kenji| Ueoka, Hiroshi| Shibayama, Takuo| Gemba, Kenichi| Kodani, Tsuyoshi| Kiura, Katsuyuki| Tabata, Masahiro| Hotta, Katsuyuki| Tanimoto, Mitsune| Sobue, Tomotaka|
抄録 <p>To evaluate recent improvements in lung cancer screening, we compared the results of recently conducted lung cancer screening with those of a previous screening. This study compared the survival of lung cancer patients detected by lung cancer screening conducted between 1976 and 1984 (early period) with that conducted between 1989 and 1997 (late period). Two hundred seventy-six patients with lung cancer were detected in the early period and 541 patients with lung cancer were detected in the late period. The median survival time (late : 49.8 vs. early : 27.8 months) and the 5-year survival rate (late : 47.8 vs. early : 34.8%) of the patients with lung cancer detected in the late period were significantly better than those in the early period (p = 0.0054). Among patients undergoing resection, the proportion of pathological stage I patients in the late period was significantly higher than that in the early period (late : 60.8 vs. early : 54.9%, p = 0.005). Multivariate analysis showed that the screening time period was a significant prognostic factor (hazard ratio = 0.685, 95% confidence interval : 0.563-0.832, p = 0.0002). These results were consistent with the findings of case-control studies of lung cancer screening programs in the late period recently conducted in Japan, which also showed a greater efficacy for screening than for previous case-control studies in the early period.</p>
キーワード lung cancer screening survival lung cancer mortality
Amo Type Article
発行日 2006-06
出版物タイトル Acta Medica Okayama
60巻
3号
出版者 Okayama University Medical School
開始ページ 173
終了ページ 179
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
論文のバージョン publisher
査読 有り
PubMed ID 16838046
Web of Science KeyUT 000238503600005
JaLCDOI 10.18926/AMO/31705
フルテキストURL fulltext.pdf
著者 Takata, Ichiro| Ueoka, Hiroshi| Kiura, Katsuyuki| Tabata, Masahiro| Takigawa, Nagio| Katayama, Hideki| Takemoto, Mitsuhiro| Hiraki, Yoshio| Harada, Mine| Tanimoto, Mitsune|
抄録 <p>A pilot study was conducted to assess the efficacy and feasibility of daily low-dose cisplatin with concurrent thoracic irradiation for clinically unresectable non-small-cell lung cancer (NSCLC). Patients with inoperable NSCLC who had poor risk factors such as advanced age, poor performance status, poor lung function, or concomitant active malignancy were entered into the study. Low-dose cisplatin (6 mg/m2) was administered daily before concurrent thoracic irradiation (2 Gy/day; total dose of 60 Gy) was given. Twenty-five patients were registered. The majority of the patients had either stage IIIA (24.0%) or stage IIIB (60.0%) disease. Fifteen patients (60.0%) completed the planned treatment. Both chemotherapy and radiotherapy were stopped in 3 patients (12.0%) due to poor response, and 7 patients (28.0%) partly received radiotherapy alone as a result of their toxicity response. The proportion of total administered dose to planned dose was 90.9% for chemotherapy and 99.3% for radiotherapy, which were comparable to those in previous studies for LA-NSCLC patients without poor risk factors. Grade 3 leukopenia and neutropenia developed in 14 patients (56.0%) and 10 patients (40.0%), respectively, but grade 4 toxicity was not encountered. Grade 3 pneumonitis and esophagitis were observed in 4 patients (16.0%) and 2 patients (8.0%), respectively. The overall response rate was 60.0%. The median survival time was 22 months, and the 2-year survival rate was 50.3%. Daily low-dose cisplatin and concurrent thoracic irradiation were well tolerated even by poor-risk patients with NSCLC, and showed a therapeutic efficacy similar to that for good-risk patients.</p>
キーワード non-small-cell lung cancer concurrent chemoradiotherapy low-dose cisplatin poor-risk factor
Amo Type Article
発行日 2002-10
出版物タイトル Acta Medica Okayama
56巻
5号
出版者 Okayama University Medical School
開始ページ 261
終了ページ 266
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
論文のバージョン publisher
査読 有り
PubMed ID 12530510
Web of Science KeyUT 000178668100007
JaLCDOI 10.18926/AMO/31706
フルテキストURL fulltext.pdf
著者 Shibakura, Misako| Niiya, Kenji| Kiguchi, Toru| Nakata, Yasunari| Tanimoto, Mitsune|
抄録 <p>We previously reported that anthracyclines, which could generate reactive oxygen species (ROS), could induce the urokinase-type plasminogen activator (uPA) gene expression in human RC-K8 malignant lymphoma cells and in H69 small cell lung cancer (SCLC) cells. In screening other uPA-inducible anti-cancer agents, we found that camptothecin (CPT) and its derivative, SN38, could induce uPA in RC-K8 and H69 cells. CPT and SN38, which are also used for the treatment of lymphoma and SCLC, significantly increased the uPA accumulation in the conditioned media of both cells in a dose-dependent manner. The maximum induction of uPA mRNA levels was observed 24 h after stimulation. Pretreatment with pyrrolidine dithiocarbamate (PDTC), an anti-oxidant, inhibited the CPT-induced uPA mRNA expression. Thus, CPT induces uPA through gene expression, and, therefore, CPT may influence the tumor-cell biology by up-regulating the uPA/plasmin system.</p>
キーワード CPT SN38 uPA RC-K8 H69
Amo Type Article
発行日 2002-10
出版物タイトル Acta Medica Okayama
56巻
5号
出版者 Okayama University Medical School
開始ページ 223
終了ページ 227
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
論文のバージョン publisher
査読 有り
PubMed ID 12530505
Web of Science KeyUT 000178668100002
JaLCDOI 10.18926/AMO/31714
フルテキストURL fulltext.pdf
著者 Kawada, Kazuhiko| Yonei, Toshiro| Ueoka, Hiroshi| Kiura, Katsuyuki| Tabata, Masahiro| Takigawa, Nagio| Harada, Mine| Tanimoto, Mitsune|
抄録 <p>When the development of chemotherapeutic agents reaches the clinical trial stage, it is necessary to perform drug sensitivity tests quickly in order to select the most promising agents for the treatment of cancer. In order to assess the possibility of using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as a substitute for the human tumor clonogenic assay (HTCA), we evaluated the correlation between the results obtained by these 2 assays in 5 human lung cancer cell lines. The correlation coefficient between the results of the HTCA and the MTT assay was 0.673, indicating a relatively good correlation. The correlation was most prominent in platinum analogues (r = 0.939) and good in anthracyclines/anthracenedione (r = 0.611). However, no significant correlation was observed in vinca alkaloids, etoposide, irinotecan, SN-38 (an active metabolite of irinotecan), and rhizoxin. The results of the MTT assay showed a high degree of correlation with those of the HTCA in predicting the sensitivity of cancer cell lines to platinum analogues, and anthracyclines/anthracenedione. These results suggest that the MTT assay may be more convenient and quickly performed than the HTCA and can replace HTCA in evaluating the effects of anticancer agents, especially the platinum analogues and anthracyclines/anthracenedione.</p>
キーワード chemosensitivity test 3-(4 5-dimethylthiazol-2-yl)-2 5-diphenyltertrazolium bromide (MTT) assay clonogenic assay
Amo Type Article
発行日 2002-06
出版物タイトル Acta Medica Okayama
56巻
3号
出版者 Okayama University Medical School
開始ページ 129
終了ページ 134
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
論文のバージョン publisher
査読 有り
PubMed ID 12108583
Web of Science KeyUT 000176521200002
JaLCDOI 10.18926/AMO/31813
フルテキストURL fulltext.pdf
著者 Kobayashi, Koichiro| Ogasawara, Masahiro| Kiyama, Yoshio| Miyazono, Takayoshi| Kagawa, Kumiko| Imai, Kiyotoshi| Hirano, Teiichi| Kobayashi, Naoki| Tanimoto, Mitsune| Kasai, Masaharu|
抄録 <p>A 23-year old woman with acute biphenotypic leukemia (ABL) complained of chest pain with cough, high fever and hemoptysis during induction chemotherapy, although she had been treated with anti-biotics and micafungin. We made a clinical diagnosis of invasive pulmonary aspergillosis (IPA) based on a consolidation in the right upper lung field on a chest radiograph as well as a high level of serum beta-D-glucan (with no evidence of tuberculosis and candidiasis). We changed her treatment from micafungin to voriconazole. Later, we discovered an air-crescent sign by CT scan that supported the diagnosis of IPA. Following voriconazole treatment, clinical symptoms ceased and abnormal chest shadows improved gradually and concurrently with a recovery of neutrophils. IPA must be considered in immunocompromised patients with pulmonary infiltrates who do not respond to broad-spectrum antibiotics. Serological tests and CT findings can aid in early diagnosis of IPA, which, along with treatment for IPA, will improve clinical outcomes.</p>
キーワード invasive pulmonary aspergillosis voriconazole acute biphenotypic leukemia febrile neutropenia ?-D-glucan
Amo Type Case Report
発行日 2009-08
出版物タイトル Acta Medica Okayama
63巻
4号
出版者 Okayama University Medical School
開始ページ 213
終了ページ 216
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
論文のバージョン publisher
査読 有り
PubMed ID 19727206
Web of Science KeyUT 000269228400007